Quoi de neuf en thérapeutique dermatologique ?
-
Published:2020-12
Issue:12
Volume:147
Page:12S43-12S50
-
ISSN:0151-9638
-
Container-title:Annales de Dermatologie et de Vénéréologie
-
language:fr
-
Short-container-title:Annales de Dermatologie et de Vénéréologie
Reference90 articles.
1. Joly P, Tejedor I, Tetart F, Cailleux HC, Barrel A, De Preville PA, et al. Tacrolimus 0.1% versus ciclopiroxolamine 1% for maintenance therapy in patients with severe facial seborrheic dermatitis a multicenter, double-blind, randomized controlled study. J Am Acad Dermatol. 2020 Sep 30;
2. Recommendations for rosacea diagnosis, classifica tion and management: update from the global ROSacea COnsensus 2019 panel;Schaller;Br J Dermatol,2020
3. Standard management options for rosacea: The 2019 update by the National Rosacea Society Expert Committee;Thiboutot;J Am Acad Dermatol,2020
4. Use of beta-blockers for rosacea-associated facial erythema and flushing: A systematic review and update on proposed mode of action;Logger;J Am Acad Dermatol,2020
5. A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40-mg modified-release capsules, versus topical ivermectin 1% cream and placebo in the treatment of severe rosacea;Schaller;J Am Acad Dermatol,2020